Divis Laboratories Ltd | DIVI - Pre Tax Profit

Stock Price
6,905.50
Daily Change
70.50 1.03%
Monthly
9.96%
Yearly
7.02%
Q2 Forecast
6,615.83

Divis Laboratories Ltd reported INR8.54B in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Aurobindo Pharma INR 14.04B 1.28B Dec/2025
Avita Medical AUD -11.64M 12.13M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Divis Laboratories Ltd INR 8.54B 580M Dec/2025
Ionis Pharmaceuticals USD -93M 135M Mar/2026
IQVIA Holdings USD 6.22B 5.68B Mar/2026
Lupin INR 19.49B 583.6M Dec/2025
Moderna USD -799M 612M Dec/2025
Organon & Co USD -148M 391M Dec/2025
Revvity USD 91.56M 35.88M Dec/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Tilray USD -39.96M 39.19M Sep/2025
Viatris USD -343M 335.1M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025